Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: A network meta-analysis

Journal of the American Geriatrics Society

Volumn 63, Issue 5, 2015, Pages 1002-1009

  Thorlund, Kristian ^a,b,c   Druyts, Eric ^c,d   Wu, Ping ^c   Balijepalli, Chakrapani ^c   Keohane, Denis ^e   Mills, Edward ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c Redwood Outcomes   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e PFIZER INC   (United States)

Author keywords

antidepressants; comparative efficacy; comparative safety; network meta analysis; older adults

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE; ADRENERGIC RECEPTOR AFFECTING AGENT;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; COMPARATIVE STUDY; DEPRESSION; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EMBASE; FAINTNESS; HAMILTON DEPRESSION RATING SCALE; HUMAN; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT RISK; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; UNCONSCIOUSNESS; VERTIGO; WEB OF SCIENCE; AGED; DEPRESSIVE DISORDER, MAJOR; TREATMENT OUTCOME;

ADRENERGIC UPTAKE INHIBITORS; AGED; DEPRESSIVE DISORDER, MAJOR; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84929653765     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13395     Document Type: Article

References (63)

1. WHO. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO Press, 2004.
2. Bromet E, Andrade LH, Hwang I, et al., Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011; 9: 90.
3. Kessler RC, Berglund P, Demler O, et al., The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095-3105.
4. Charles ST, Reynolds CA, Gatz M,. Age-related differences and change in positive and negative affect over 23 years. J Pers Soc Psychol 2001; 80: 136-151.
5. Schieman S, Van Gundy K, Taylor J,. The relationship between age and depressive symptoms: A test of competing explanatory and suppression influences. J Aging Health 2002; 14: 260-285.
6. Hasin DS, Goodwin RD, Stinson FS, et al., Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005; 62: 1097-1106.
7. Alexopoulos GS,. Depression in the elderly. Lancet 2005; 365: 1961-1970.
8. Blazer DG,. Depression in late life: Review and commentary. J Gerontol A Biol Sci Med Sci 2003; 58A: 249-265.
9. Fiske A, Wetherell JL, Gatz M,. Depression in older adults. Ann Rev Clin Psychol 2009; 5: 363-389.
10. Hare DL, Toukhsati SR, Johansson P, et al., Depression and cardiovascular disease: A clinical review. Eur Heart J 2014; 35: 1365-1372.
11. Thombs BD, de Jonge P, Coyne JC, et al., Depression screening and patient outcomes in cardiovascular care: A systematic review. JAMA 2008; 300: 2161-2171.
12. Hackett ML, Pickles K,. Part I: Frequency of depression after stroke: An updated systematic review and meta-analysis of observational studies. Int J Stroke 2014; 9: 1017-1025.
13. Paolucci S,. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat 2008; 4: 145-154.
14. Cole MG, McCusker J, Ciampi A, et al., Risk factors for major depression in older medical inpatients: A prospective study. Am J Geriatr Psychiatry 2008; 16: 175-178.
15. Heun R, Hein S,. Risk factors of major depression in the elderly. Eur Psychiatry 2005; 20: 199-204.
16. Weyerer S, Eifflaender-Gorfer S, Kohler L, et al., Prevalence and risk factors for depression in non-demented primary care attenders aged 75 years and older. J Affect Disord 2008; 111: 153-163.
17. Coupland C, Dhiman P, Morriss R, et al., Antidepressant use and risk of adverse outcomes in older people: Population based cohort study. BMJ 2011; 343: d4551.
18. Giron MS, Fastbom J, Winblad B,. Clinical trials of potential antidepressants: To what extent are the elderly represented: A review. Int J Geriatr Psychiatry 2005; 20: 201-217.
19. Pollock BG,. Adverse reactions of antidepressants in elderly patients. J Clin Psychiatry 1999; 60 (Suppl 20): 4-8.
20. Calati R, Salvina Signorelli M, Balestri M, et al., Antidepressants in elderly: Meta-regression of double-blind, randomized clinical trials. J Affect Disord 2013; 147: 1-8.
21. Kok RM, Heeren TJ, Nolen WA,. Continuing treatment of depression in the elderly: A systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants. Am J Geriatr Psychiatry 2011; 19: 249-255.
22. Kok RM, Nolen WA, Heeren TJ,. Efficacy of treatment in older depressed patients: A systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord 2012; 141: 103-115.
23. Nelson JC, Delucchi K, Schneider LS,. Efficacy of second generation antidepressants in late-life depression: A meta-analysis of the evidence. Am J Geriatr Psychiatry 2008; 16: 558-567.
24. Seitz DP, Gill SS, Conn DK,. Citalopram versus other antidepressants for late-life depression: A systematic review and meta-analysis. Int J Geriatr Psychiatry 2010; 25: 1296-1305.
25. Sneed JR, Rutherford BR, Rindskopf D, et al., Design makes a difference: A meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008; 16: 65-73.
26. Tedeschini E, Levkovitz Y, Iovieno N, et al., Efficacy of antidepressants for late-life depression: A meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry 2011; 72: 1660-1668.
27. Mills EJ, Ioannidis JP, Thorlund K, et al., How to use an article reporting a multiple treatment comparison meta-analysis. JAMA 2012; 308: 1246-1253.
28. Dias S, Sutton A, Welton N, et al., NICE DSU Technical Support Document 2-A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trial. 2011. Report by the Decision Support Unit. Available at http://www.nicedsu.org.uk/TSD3%20Heterogeneity-final%20report-docx.pdf Accessed May 1, 2014.
29. Lu G, Ades AE,. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23: 3105-3124.
30. Dias S, Welton NJ, Sutton AJ, et al., Evidence synthesis for decision making 4: Inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making 2013; 33: 641-656.
31. Jansen J, Naci H,. Is network meta-analysis as valid as standard pair-wise meta-analysis? It all depends on the distribution of effect-modifiers. BMC Med 2013; 11: 159.
32. Bucher HC, Guyatt GH, Griffith LE, et al., The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997; 50: 683-691.
33. Dias S, Sutton A, Welton N, et al., NICE DSU Technical Support Document 3-Heterogeneity: Subgroups, Meta-regression, Bias, and Bias-adjustment, 2011 [on-line]. Available at https://www.cc-arcc.ca/com Accessed May 1, 2014.
34. Ather SA, Ankier SI, Middleton RS,. A double-blind evaluation of trazodone in the treatment of depression in the elderly. Br J Clin Pract 1985; 39: 192-199.
35. Bose A, Li D, Gandhi C,. Escitalopram in the acute treatment of depressed patients aged 60 years or older. Am J Geriatr Psychiatry 2008; 16: 14-20.
36. De Ronchi D, Rucci P, Lodi M, et al., Fluoxetine and amitriptyline in elderly depressed patients. A 10-week, double-blind study on course of neurocognitive adverse events and depressive symptoms. Arch Gerontol Geriatr 1998; 26 (Suppl 1): 125-140.
37. Falk WE, Rosenbaum JF, Otto MW, et al., Fluoxetine versus trazodone in depressed geriatric patients. J Geriatr Psychiatry Neurol 1989; 2: 208-214.
38. Geretsegger C, Stuppaeck CH, Mair M, et al., Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmacology 1995; 119: 277-281.
39. Hutchinson DR, Tong S, Moon CA, et al., Paroxetine in the treatment of elderly depressed patients in general practice: A double-blind comparison with amitriptyline. Int Clin Psychopharmacol 1992; 6 (Suppl 4): 43-51.
40. Kasper S, de Swart H, Friis Andersen H,. Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry 2005; 13: 884-891.
41. Kyle CJ, Petersen HE, Overo KF,. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Depress Anxiety 1998; 8: 147-153.
42. Rapaport MH, Lydiard BR, Pitts CD, et al., Low doses of controlled-release paroxetine in the treatment of late-life depression: A randomized, placebo-controlled trial. J Clin Psychiatry 2009; 1: 46-57.
43. Rapaport MH, Schneider LS, Dunner DL, et al., Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry 2003; 64: 1065-1074.
44. Raskin J, Wiltse CG, Siegal A, et al., Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial. Am J Psychiatry 2007; 164: 900-909.
45. Roose SP, Sackeim HA, Krishnan KR, et al., Antidepressant pharmacotherapy in the treatment of depression in the very old: A randomized, placebo-controlled trial. Am J Psychiatry 2004; 161: 2050-2059.
46. Schatzberg A, Roose S,. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Am J Geriatr Psychiatry 2006; 14: 361-370.
47. Schneider LS, Nelson JC, Clary CM, et al., An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 2003; 160: 1277-1285.
48. Tollefson GD, Bosomworth JC, Heiligenstein JH, et al., A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group. Int Psychogeriatr 1995; 7: 89-104.
49. Revicki DA, Simon GE, Chan K, et al., Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment. J Fam Pract 1998; 47: 446-452.
50. Kroenke K, West SL, Swindle R, et al., Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial. JAMA 2001; 286: 2947-2955.
51. Corey-Lisle PK, Nash R, Stang P, et al., Response, partial response, and nonresponse in primary care treatment of depression. Arch Intern Med 2004; 164: 1197-1204.
52. Steffens DC, Krishnan KR, Helms MJ,. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: A meta-analysis. Depress Anxiety 1997; 6: 10-18.
53. Reimherr FW, Chouinard G, Cohn CK, et al., Antidepressant efficacy of sertraline: A double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990; 51 (Suppl B): 18-27.
54. Trindade E, Menon D, Topfer LA, et al., Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis. Can Med Assoc J 1998; 159: 1245-1252.
55. Fava M,. Weight gain and antidepressants. J Clin Psychiatry 2000; 61 (Suppl 11): 37-41.
56. Kerse N, Flicker L, Pfaff JJ, et al., Falls, depression and antidepressants in later life: A large primary care appraisal. PLoS One 2008; 3: e2423.
57. Darowski A, Chambers SA, Chambers DJ,. Antidepressants and falls in the elderly. Drugs Aging 2009; 26: 381-394.
58. Ciechanowski P, Wagner E, Schmaling K, et al., Community-integrated home-based depression treatment in older adults: A randomized controlled trial. JAMA 2004; 291: 1569-1577.
59. Mills EJ, Thorlund K, Ioannidis JP,. Demystifying trial networks and network meta-analysis. BMJ 2013; 346: f2914.
60. Thorlund K, Mills EJ,. Sample size and power considerations in network meta-analysis. Syst Rev 2012; 1: 41.
61. Mills EJ, Bansback N, Ghement I, et al., Multiple treatment comparison meta-analyses: A step forward into complexity. Clin Epidemiol 2011; 3: 193-202.
62. Ioannidis JP,. Ranking antidepressants. Lancet 2009; 373: 1759-1760; author reply 1761-1762.
63. Montgomery SA, Moller HJ,. Is the significant superiority of escitalopram compared with other antidepressants clinically relevant? Int Clin Psychopharmacol 2009; 24: 111-118.